Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report

This is the authors' abstract. We don't add key points for this paper.

ing elimination diets, antiallergic agents, and immunomodulators, have been suggested, whereas more effective treatment options are awaited. 4,5edolizumab is a humanized monoclonal antibody to the α4β7 integrin, preventing binding to its ligand, mucosal addressing cell adhesion molecule-1 (MadCAM-1).Vedolizumab is approved for the treatment of inflammatory bowel diseases and provides anti-inflammatory effect via specific inhibition of GI migration of effector T lymphocytes. 6[10] We herein described a case of EGE with ulcerative colitis (UC) successfully treated with vedolizumab and discuss the efficacy of vedolizumab for EGE.Informed consent was obtained from the patient for being included in the report.